Lhc Group Inc Revenue Growth Rates (LHCG), Current and Historic Growth - CSIMarket
CSIMarket
 


Lhc Group Inc   (NASDAQ: LHCG)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

LHCG's Revenue Growth by Quarter and Year

Lhc Group Inc 's Revenue results by quarter and year




LHCG Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December 558.17
3rd Quarter September 576.91
2nd Quarter June 576.19
1st Quarter March 571.50
FY 2,282.77

LHCGs Annual Revenue
Lhc Group Inc 's Revenue in the fiscal year 2022 $ 2,282.77 millions
Lhc Group Inc 's Revenue in the fiscal year 2021 $ 2,219.62 millions
Lhc Group Inc 's Revenue in the fiscal year 2020 $ 2,063.20 millions
Lhc Group Inc 's Revenue in the fiscal year 2019 $ 2,080.24 millions
Lhc Group Inc 's Revenue in the fiscal year 2018 $ 1,809.96 millions




LHCG Revenue fourth quarter 2022 Y/Y Growth Comment
Lhc Group Inc reported decrease in Revenue in the fourth quarter 2022 by -4.33% to $ 558.17 millions, from the same quarter in 2021.
The decrease in the fourth quarter 2022 Lhc Group Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 15.41%.

Looking into fourth quarter 2022 results within Healthcare Facilities industry 37 other companies have achieved higher Revenue growth. While Lhc Group Inc ' s Revenue decline of -4.33% ranks overall at the positon no. 2917 in the fourth quarter 2022.




LHCG Revenue ( Y/Y Growth %) 2022
2021 2020 2019
4th Quarter December -4.33 % 9.6 % 0.19 % 4.21 %
3rd Quarter September 2.03 % 6.55 % 0.41 % 4.23 %
2nd Quarter June 5.55 % 12.02 % -5.89 % 3.15 %
1st Quarter March 8.89 % 2.33 % 2.05 % 72.68 %
FY   2.84 % 7.58 % -0.82 % -

Financial Statements
Lhc Group Inc 's fourth quarter 2022 Revenue $ 558.17 millions LHCG's Income Statement
Lhc Group Inc 's fourth quarter 2021 Revenue $ 583.43 millions Quarterly LHCG's Income Statement


LHCG Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
4th Quarter December -3.25 % 3.18 % 0.31 % 0.53 %
3rd Quarter September 0.12 % 3.58 % 8.9 % 2.06 %
2nd Quarter June 0.82 % 4.01 % -4.98 % 3.03 %
1st Quarter March -2.04 % -1.41 % -3.47 % -1.42 %
FY (Year on Year)   2.84 % 7.58 % -0.82 % -




Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #38
Healthcare Sector #424
Overall #2917

Revenue Y/Y Growth Statistics
High Average Low
92.93 % 15.41 % -5.89 %
(Jun 30 2018)   (Jun 30 2020)
Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #38
Healthcare Sector #424
Overall #2917
Revenue Y/Y Growth Statistics
High Average Low
92.93 % 15.41 % -5.89 %
(Jun 30 2018)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Lhc Group Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
72.48 % 3.41 % -4.98 %
(Jun 30 2018)  


LHCG's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2022 Lhc Group Inc disclosed fall in Revenue from the third quarter by -3.25% to $ 558.17 millions, from $ 576.91 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2022 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.

Within Healthcare Facilities industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Lhc Group Inc 's Revenue growth quarter on quarter, overall rank is 2822.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #39
Healthcare Sector #502
Overall #2822
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #39
Healthcare Sector #502
Overall #2822
Revenue Q/Q Growth Statistics
High Average Low
72.48 % 3.41 % -4.98 %
(Jun 30 2018)  


LHCG's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2022 Lhc Group Inc disclosed fall in Revenue from the third quarter by -3.25% to $ 558.17 millions, from $ 576.91 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2022 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.

Within Healthcare Facilities industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Lhc Group Inc 's Revenue growth quarter on quarter, overall rank is 2822.


Lhc Group Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 2,282.77 $ 2,308.03 $ 2,296.57 $ 2,266.28 $ 2,219.62
Y / Y Revenue Growth (TTM) 2.85 % 6.43 % 7.63 % 9.21 % 7.58 %
Year on Year Revenue Growth Overall Ranking # 2335 # 1133 # 2277 # 961 # 1596
Seqeuential Revenue Change (TTM) -1.09 % 0.5 % 1.34 % 2.1 % 2.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 2784 # 1275 # 2468 # 850 # 2954


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Lhc Group Inc 's cumulative twelve months Revenue were $ 2,283 millions, company would post below average annual Revenue growth of 2.36% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Lhc Group Inc 's Revenue growth from the 576.91% growth in Sep 30 2022.

In the Healthcare sector 302 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1133 to 2335.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 303
Overall # 2335

Revenue TTM Y/Y Growth Statistics
High Average Low
81.05 %
15.94 %
-0.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 374
S&P 500 # 2784
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Lhc Group Inc 's cumulative twelve months Revenue were $ 2,283 millions, company would post below average annual Revenue growth of -0.82% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Lhc Group Inc 's Revenue growth from the 576.91% growth in Sep 30 2022.

In the Healthcare sector 302 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1133 to 2335.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 303
Overall # 2335

Revenue TTM Y/Y Growth Statistics
High Average Low
81.05 %
15.94 %
-0.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 374
S&P 500 # 2784




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LHCG's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Amgen Inc -0.10%$ -0.102 millions
Bausch Health Companies Inc -0.14%$ -0.137 millions
Bio rad Laboratories Inc -0.34%$ -0.339 millions
Nrc Health-0.40%$ -0.402 millions
Asensus Surgical Inc -0.48%$ -0.485 millions
Bausch and Lomb Corp-0.50%$ -0.500 millions
Teleflex Incorporated-0.51%$ -0.514 millions
Elite Pharmaceuticals Inc -0.62%$ -0.619 millions
Meihua International Medical Technologies Co Ltd-0.66%$ -0.665 millions
Ambrx Biopharma Inc -0.71%$ -0.711 millions
Chemed Corporation-0.85%$ -0.851 millions
Vycor Medical Inc -0.90%$ -0.899 millions
Fonar Corporation-0.91%$ -0.911 millions
Davita Inc -0.92%$ -0.920 millions
Syneos Health Inc -0.98%$ -0.984 millions
Reshape Lifesciences Inc-1.02%$ -1.018 millions
Accuray Incorporated-1.30%$ -1.303 millions
Bellicum Pharmaceuticals Inc -1.57%$ -1.575 millions
Pliant Therapeutics Inc -1.70%$ -1.701 millions
Royalty Pharma Plc-1.73%$ -1.729 millions
Precipio inc -1.81%$ -1.807 millions
Integra Lifesciences Holdings Corp-1.85%$ -1.850 millions
Nexgel Inc -1.88%$ -1.876 millions
Novartis Ag-1.98%$ -1.984 millions
Theravance Biopharma inc -1.99%$ -1.987 millions
Orthofix Medical Inc -2.27%$ -2.267 millions
Travere Therapeutics Inc -2.41%$ -2.412 millions
Heska Corporation-2.54%$ -2.542 millions
Sangamo Therapeutics Inc -2.70%$ -2.701 millions
Glaukos Corp-2.75%$ -2.748 millions


About Lhc Group Inc Revenue Growth Rates (LHCG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Lhc Group Inc (CIK 1303313).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001303313-23-000020
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Lhc Group Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.